Company Active LTD

Company profile

Cryogenx Ltd

Cryosuit

Cryosuit

CRN
12364593
Founded
2019
Age
6

Overview

Legal name
CRYOGENX LTD
Region
London
Registered address
UNIT 12, SPECTRUM HOUSE
32-34 GORDON HOUSE ROAD
LONDON
ENGLAND
NW5 1LP
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
8

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

29 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

15 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

16 Aug
2024

Accounts With Accounts Type Micro Entity

Accounts Analysed

AA | Transaction MzQzMjQ3NDcyM2FkaXF6a2N4

Published 16 Aug 2024 09:27

16 Dec
2019

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2021
Funded years
2021, 2022
Age at first award
1 years

Projects

2022 Collaborative R&D Lead participant

Developing Cryosuit - usability and performance validation of our portable, rapid cooling device for heat-related illness.

1 Oct 2022 to 31 Mar 2024

Awarded
£217,418
Total cost £483,150

**Developing the Cryosuit - usability and performance validation of our portable, rapid cooling device for heat-related illness.** Illness and complications brought on by heat has a significant impact on population health and economies worldwide. Heatstroke causes vital organ damage, leading to serious debilitation or death, if treatment to lower core bod...

2021 Collaborative R&D Lead participant

Cryosuit - Portable body cooling for heat illness

1 Jul 2021 to 30 Nov 2022

Awarded
£141,617
Total cost £202,310

Globally 700 million people are exposed to life-threatening extreme heat (European Commission,2017). By 2030, due to the effects of climate change, heat stress will cost the global economy $2.4trn/year (UN), and heat-related deaths will increase by 257% (Public Health England,2014). Heat illness constitutes a significant source of morbidity and mortality ...

Product types

Collaborative R&D